Primolut‑N (Norethisterone) with Depo‑Provera: No Contraceptive Interference
Primolut‑N (norethisterone 5 mg) is a progestin used for menstrual regulation, endometriosis, or dysfunctional uterine bleeding. Depo‑Provera (DMPA) is a long‑acting injectable progestin contraceptive.
Interaction Assessment
- Both are progestins; no pharmacokinetic interaction that reduces DMPA’s contraceptive efficacy.
- DMPA suppresses ovulation primarily; norethisterone adds progestogenic effect (endometrial stabilization).
- No evidence of increased pregnancy risk with concurrent use.
Clinical Context
- Norethisterone often prescribed for breakthrough bleeding on DMPA (5 mg TID × 5–10 days).
- Does not “cancel out” DMPA; next DMPA injection remains on schedule (every 11–13 weeks).
Caveats
- Always inform all providers of all medications.
- If norethisterone used for other indications (e.g., endometriosis), ensure DMPA timing maintained.
- Individual metabolism varies; consult prescriber for personalized advice.
Pregnancy & Health - Related Articles
- Missed Birth Control Pill: Pregnancy Risk and What to Do
- Breakthrough Bleeding on Birth Control: Causes, Management, and When to Call Your Doctor
- Preterm Birth Prevalence: Global Rates and Regional Variations
- Smoking During Pregnancy: Health Risks for Mother and Baby
- Pregnancy Dating: LMP vs. Conception – Understanding Scan Dates
- Gallstone Medication and Pregnancy: Is There a Down Syndrome Risk?
- Early Pregnancy Symptoms: Signs Before a Positive Home Test
